FASCINATION ABOUT IL-2 THERAPY FOR MELANOMA

It's well comprehended that IL-2 is often a pleiotropic cytokine positioned in the crossroads of T mobile activation and regulation. As such, it is actually very important to engineer an IL-2 molecule that is biased to effector cells bearing the intermediate affinity receptor, including naïve and memory CD8+ T cells and NK cells, as opposed to Tre